Whole‐exome sequencing of non‐BRCA1/BRCA2 mutation carrier cases at high‐risk for hereditary breast/ovarian cancer. Issue 3 (28th December 2020)
- Record Type:
- Journal Article
- Title:
- Whole‐exome sequencing of non‐BRCA1/BRCA2 mutation carrier cases at high‐risk for hereditary breast/ovarian cancer. Issue 3 (28th December 2020)
- Main Title:
- Whole‐exome sequencing of non‐BRCA1/BRCA2 mutation carrier cases at high‐risk for hereditary breast/ovarian cancer
- Authors:
- Felicio, Paula S.
Grasel, Rebeca S.
Campacci, Natalia
de Paula, Andre E.
Galvão, Henrique C. R.
Torrezan, Giovana T.
Sabato, Cristina S.
Fernandes, Gabriela C.
Souza, Cristiano P.
Michelli, Rodrigo D.
Andrade, Carlos E.
Barros, Bruna Durães De Figueiredo
Matsushita, Marcus M.
Revil, Timothée
Ragoussis, Jiannis
Couch, Fergus J.
Hart, Steven N.
Reis, Rui M.
Melendez, Matias E.
Tonin, Patricia N.
Carraro, Dirce M.
Palmero, Edenir I. - Abstract:
- Abstract: The current study aimed to identify new breast and/or ovarian cancer predisposition genes. For that, whole‐exome sequencing (WES) was performed in the germline DNA of 52 non‐ BRCA1/BRCA2/TP53 mutation carrier women at high‐risk for hereditary breast and ovarian cancer (HBOC). All variants were classified using information from population and disease specific databases, in silico prediction tools and the American College of Medical Genetics and Genomics (ACMG) criteria. Loss of heterozygosity (LOH) of tumor samples and segregation analyses were performed whenever possible. The variants identified were investigated in a second, independent cohort of 17 BC cases. Pathogenic/Likely Pathogenic variants were identified in known cancer genes such as CHEK2, MUTYH, PMS2, and RAD51C . Rare and potentially pathogenic variants were identified in DNA repair genes ( FAN1, POLQ, and RAD54L ) and other cancer‐related genes such as DROSHA and SLC34A2 . Interestingly, the variant c.149T>G in the FAN1 gene was identified in two unrelated families, and exhibited LOH in the tumor tissue of one of them. In conclusion, this is the largest Brazilian WES study involving families at high‐risk for HBOC which has brought novel insights into the role of potentially new genetic risk factors for hereditary breast and ovarian cancer. Abstract : The current study aimed to identify new breast and/or ovarian cancer predisposition genes. Rare and potentially pathogenic variants were identified in DNAAbstract: The current study aimed to identify new breast and/or ovarian cancer predisposition genes. For that, whole‐exome sequencing (WES) was performed in the germline DNA of 52 non‐ BRCA1/BRCA2/TP53 mutation carrier women at high‐risk for hereditary breast and ovarian cancer (HBOC). All variants were classified using information from population and disease specific databases, in silico prediction tools and the American College of Medical Genetics and Genomics (ACMG) criteria. Loss of heterozygosity (LOH) of tumor samples and segregation analyses were performed whenever possible. The variants identified were investigated in a second, independent cohort of 17 BC cases. Pathogenic/Likely Pathogenic variants were identified in known cancer genes such as CHEK2, MUTYH, PMS2, and RAD51C . Rare and potentially pathogenic variants were identified in DNA repair genes ( FAN1, POLQ, and RAD54L ) and other cancer‐related genes such as DROSHA and SLC34A2 . Interestingly, the variant c.149T>G in the FAN1 gene was identified in two unrelated families, and exhibited LOH in the tumor tissue of one of them. In conclusion, this is the largest Brazilian WES study involving families at high‐risk for HBOC which has brought novel insights into the role of potentially new genetic risk factors for hereditary breast and ovarian cancer. Abstract : The current study aimed to identify new breast and/or ovarian cancer predisposition genes. Rare and potentially pathogenic variants were identified in DNA repair genes ( FAN1, POLQ, and RAD54L ) and other cancer‐related genes such as DROSHA and SLC34A2 . This is the largest Brazilian WES study involving families at high‐risk for hereditary breast and ovarian cancer which has brought novel insights into the role of potentially new genetic risk factors for hereditary breast and ovarian cancer. … (more)
- Is Part Of:
- Human mutation. Volume 42:Issue 3(2021)
- Journal:
- Human mutation
- Issue:
- Volume 42:Issue 3(2021)
- Issue Display:
- Volume 42, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 42
- Issue:
- 3
- Issue Sort Value:
- 2021-0042-0003-0000
- Page Start:
- 290
- Page End:
- 299
- Publication Date:
- 2020-12-28
- Subjects:
- BRCAX -- breast cancer predisposition -- hereditary breast and ovarian cancer predisposition syndrome -- hereditary cancer -- whole‐exome sequencing
Human chromosome abnormalities -- Periodicals
Mutation (Biology) -- Periodicals
616.04205 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-1004 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/humu.24158 ↗
- Languages:
- English
- ISSNs:
- 1059-7794
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4336.217000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15781.xml